CLINICAL_TRIALS
trial_result
· 2025-09-15
Clinical Trial Update: NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922) [Phase 1]
Summary
This update reports the completion of a Phase 1 study of lorlatinib (PF-06463922) in neuroblastoma. Results from the trial have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Phase 1 | Status: COMPLETED | Results posted: 2025-09-15